Sichenzia Ross Ference Kesner LLP Represents Laidlaw & Company (UK) Ltd. in $7 Million Public Offering
Press Release – New York, NY – February 24, 2017 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that it has represented Laidlaw & Company (UK) Ltd. as sole book-running manager in the underwritten public offering of equity securities of Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases. In connection with the offering, Evoke received approximately $7 million in gross proceeds from common stock sold at a price to the public of $2.90 per share.
The Sichenzia Ross Ference Kesner LLP team was led by partners Harvey Kesner and Avital Even-Shoshan and associate Evan Berger.
Visit SRFK's LinkedIn page
Latest posts by Sichenzia Ross Ference Kesner LLP (see all)
- Sichenzia Ross Ference Kesner LLP Represents PolarityTE, Inc., in $37.4 Million Public Offering - April 16, 2018
- Sichenzia Ross Ference Kesner LLP Represents New Age Beverages Corp. in $4 Million Underwritten Public Offering - April 12, 2018
- Sichenzia Ross Ference Kesner LLP Represents Rodman & Renshaw a unit of H.C Wainwright in a $10.5 Million Public Offering of Medical Transcript Billing, Corp. - April 11, 2018